University of Ferrara-ko ikertzaileekin lankidetzan egindako argitalpenak (10)

2008

  1. Binding of the novel radioligand [3H]UFP-101 to recombinant human and native rat nociceptin/orphanin FQ receptors

    Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 378, Núm. 6, pp. 553-561

2007

  1. In vitro and in vivo pharmacological profile of UFP-512, a novel selective δ-opioid receptor agonist; correlations between desensitization and tolerance

    British Journal of Pharmacology, Vol. 152, Núm. 8, pp. 1312-1324

2003

  1. Characterization of nociceptin/orphanin FQ binding sites in dog brain membranes

    Anesthesia and Analgesia, Vol. 97, Núm. 3, pp. 741-747

2001

  1. Structure-activity studies of the Phe4 residue of nociceptin(1-13)-NH2: Identification of highly potent agonists of the nociceptin/orphanin FQ receptor

    Journal of Medicinal Chemistry, Vol. 44, Núm. 23, pp. 3956-3964

2000

  1. Characterization of N,N(Me)2-Dmt-Tic-OH, a delta selective opioid dipeptide antagonist

    NeuroReport, Vol. 11, Núm. 10, pp. 2083-2086

  2. Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor

    Journal of Medicinal Chemistry, Vol. 43, Núm. 15, pp. 2805-2813

1999

  1. Differential knockdown of δ-opioid receptor subtypes in the rat brain by antisense oligodeoxynucleotides targeting mRNA

    Antisense and Nucleic Acid Drug Development, Vol. 9, Núm. 2, pp. 203-211

  2. Nociceptin binding sites in frog (Rana esculenta) brain membranes

    Biochemical and Biophysical Research Communications, Vol. 260, Núm. 3, pp. 592-596

  3. Pharmacology of [Tyr1]nociceptin analogs: Receptor binding and bioassay studies

    Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 360, Núm. 3, pp. 270-277

1998

  1. Nociceptin receptor binding in mouse forebrain membranes: Thermodynamic characteristics and structure activity relationships

    British Journal of Pharmacology, Vol. 125, Núm. 7, pp. 1485-1490